Trusted resource of information on AIDS/HIV that includes articles, news, videos, animations, quizzes, calculators and drugs ...

Siltuximab is under clinical development by Recordati and currently in Phase II for Pain. According to GlobalData, Phase II drugs for Pain have a 44% phase transition success rate (PTSR) indication ...